NASDAQ: BCTX
Briacell Therapeutics Corp Stock Ownership - Who owns Briacell Therapeutics?

Insider buying vs selling

Have Briacell Therapeutics Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BCTX insiders and whales buy or sell their stock.

BCTX Shareholders

What type of owners hold Briacell Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc Lustig61.73%4,182,935$3.44MInsider
Jamieson Bondarenko2.51%169,856$139.62kInsider
Williams V. Williams2.21%149,636$123.00kInsider
Ubs Group Ag0.28%19,066$15.67kInstitution
Vaughn C. Embropantalony0.14%9,524$7.83kInsider
Group One Trading LLC0.04%2,925$2.40kInstitution
Gadi Levin0.04%2,810$2.31kInsider
Royal Bank Of Canada0.01%1,000$822.00Institution
National Bank Of Canada0.01%944$775.97Institution
Sbi Securities Co Ltd0.01%600$493.20Institution

1 of 3

BCTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCTX0.38%66.64%
XBIO2.58%97.42%
TCRT0.25%99.75%Net Buying
QLGN0.05%99.95%
GTBP3.85%46.64%

Briacell Therapeutics Stock Ownership FAQ

Who owns Briacell Therapeutics?

Briacell Therapeutics (NASDAQ: BCTX) is owned by 0.38% institutional shareholders, 66.64% Briacell Therapeutics insiders, and 32.98% retail investors. Marc Lustig is the largest individual Briacell Therapeutics shareholder, owning 4.18M shares representing 61.73% of the company. Marc Lustig's Briacell Therapeutics shares are currently valued at $3.48M.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.